Apyx Medical Corp 8-K

What Happened
Apyx Medical Corporation announced its results of operations for the fourth quarter and full year ended December 31, 2025 in a press release issued March 10, 2026. The company furnished that press release as Exhibit 99.1 to its Form 8‑K (filed March 10, 2026) under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Press release date: March 10, 2026.
• Reporting period: Quarter and year ended December 31, 2025 (Q4 2025 and FY 2025).
• Filing: Form 8‑K furnished under Item 2.02; Exhibit 99.1 (earnings press release) attached.
• Interactive XBRL cover page (Exhibit 104) included with the filing.

Why It Matters
This filing signals that Apyx has publicly released its latest quarterly and annual operating results—key information for investors evaluating recent revenue, profitability, cash flow, and trends. Retail investors should review the attached press release for the company’s reported revenue, net income (or loss), guidance (if provided), and management commentary, and then consult the company’s subsequent SEC filings (quarterly/annual reports) for audited financial statements and more detail.